IL17A and ulcerative colitis: To explore CRISPR-Select modeling of a noncancer disease, we tested loss-of-function variants in NFKBIZ in the IL-17A signaling pathway, which have been identified in ulcerative colitis colon epithelium and shown to confer survival advantage to colon epithelial organoids29,30.